Original article

Cost of hospitalization of patients with hepatolenticular degeneration in southwest of China: data analysis during 2005-2020

Expand
  • 1. Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China
    2. Department of Geriatric Medicine and Neurology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
    3. West China School of Public Health, Sichuan University, Chengdu 610041, China

Received date: 2021-06-20

  Online published: 2022-07-25

Abstract

Objective To analyze the hospitalization cost of the patients with hepatolenticular degeneration in southwest of China. Methods The data of hospitalization cost of the patients with hepatolenticular degeneration were acquired from electronic medical record system in West China Fourth Hospital from 2005 to 2020. Multiple linear regression analysis was utilized for analyzing the factors of hospitalization cost retrospectively, and covariance analysis was used for controlling the confounding factors. SPSS 20.0 (IBM) was applied for data analysis. Results A total of 346 patients with hepatolenticular degeneration were enrolled in our analysis. The year of admission, age, number of comorbidities, days of hospitalization, and complication of decompensated liver cirrhosis were the factors to influence the cost of hospitalization. After the confounding factors were adjusted, the hospitalization cost grew following the increase of comorbidity number, and complication of decompensated liver cirrhosis also led to the increase of hospitalization cost. The hospitalization cost of 2005-2006 and 2007-2008 were lower than those in the rest of years. Conclusions Hospitalization cost of the patients with hepatolenticular degeneration in southwest of China were influenced by number of comorbidities, complication of decompensated liver cirrhosis, and year to admit. It was important to reduce the occurrence of complication and decompensated liver cirrhosis, as to reduce the cost of hospitalization.

Cite this article

HONG Peiwei, CONG Xue, XU Yanming . Cost of hospitalization of patients with hepatolenticular degeneration in southwest of China: data analysis during 2005-2020[J]. Journal of Internal Medicine Concepts & Practice, 2021 , 16(05) : 315 -318 . DOI: 10.16138/j.1673-6087.2021.05.006

References

[1] Chang IJ, Hahn SH. The genetics of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 19-34.
[2] Scheiber IF, Bruha R, Dušek P. Pathogenesis of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 43-55.
[3] Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features[J]. Handb Clin Neurol, 2017, 142: 101-119.
[4] Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 91-99.
[5] Dziezyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 157-169.
[6] Lo C, Bandmann O. Epidemiology and introduction to the clinical presentation of Wilson disease[J]. Handb Clin Neurol, 2017, 142: 7-17.
[7] 胡文彬, 韩咏竹, 薛本春, 等. 安徽省含山县肝豆状核变性的流行病学研究[J]. 中华医学杂志, 2011, 91(13):894-897.
[8] Cheng N, Wang K, Hu W, et al. Wilson disease in the South Chinese Han population[J]. Can J Neurol Sci, 2014, 41(3): 363-367.
[9] 陈晨. 肝豆状核变性患者疾病经济负担的调查与分析[D]. 上海: 上海交通大学, 2015.
[10] European Association for Study of Liver. EASL clinical practice guidelines: Wilson’s disease[J]. J Hepatol, 2012, 56(3): 671-685.
[11] Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis[J]. Br Med J (Clin Res Ed), 1986, 292(6512): 13-15.
[12] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志, 2019, 27(11): 846-865.
[13] 韩小敬. 基于中医临床路径的肝豆状核变性卫生经济学评价[D]. 安徽: 安徽中医药大学, 2016.
Outlines

/